[1]李薇薇,刘丹宁,周希瑗.儿童视网膜母细胞瘤的基因型及临床表型分析[J].第三军医大学学报,2020,42(18):1859-1867.
 LI Weiwei,LIU Danning,ZHOU Xiyuan.Analysis of gene mutations and clinical phenotypes in children with retinoblastoma[J].J Third Mil Med Univ,2020,42(18):1859-1867.
点击复制

儿童视网膜母细胞瘤的基因型及临床表型分析(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
42卷
期数:
2020年第18期
页码:
1859-1867
栏目:
临床医学
出版日期:
2020-09-30

文章信息/Info

Title:
Analysis of gene mutations and clinical phenotypes in children with retinoblastoma
作者:
李薇薇刘丹宁周希瑗
重庆医科大学附属第二医院眼科
Author(s):
LI Weiwei LIU Danning ZHOU Xiyuan

Department of Ophthalmology, the Second Hospital Affiliated of Chongqing Medical University, Chongqing, 400010, China

关键词:
视网膜母细胞瘤基因突变拷贝数异常
Keywords:
retinoblastoma gene mutation copy number variations
分类号:
R394.3;R730.23;R739.72
文献标志码:
A
摘要:

目的分析儿童视网膜母细胞瘤(retinoblastoma, RB)基因突变与临床表型的特点。方法收集2018-2019年重庆医科大学附属第二医院门诊23例(双眼4例,单眼19例)散发性RB患儿,联合全外显子测序以及甲基化测序等方法对其外周血样本进行分子遗传学筛查。结合患儿临床表型及分子遗传学特征进行数据分析。结果23例RB患儿中检测到5例胚系突变,其中3例为RB1基因点突变(c.1333C>T无义突变、c.380G>A错义突变以及c.1940delT移码突变各1例),2例为拷贝数变异(1例RB1基因5~17号外显子杂合缺失以及1例RB1基因及邻近序列约14 Mb片段杂合缺失)。5例基因突变患儿的平均发病年龄为5.4个月,显著早于未突变患儿的发病年龄20.2个月,且基因突变与发病年龄有相关性(r=0.592,P<0.01)。5例基因突变患儿中有3例双眼(3/4)RB,显著高于单眼RB检出率(2/19),累及眼别亦有显著差异(χ2=8.074,P<0.01)。结论2例新型RB1基因胚系拷贝数变异,补充了RB1基因变异谱;RB1基因胚系突变导致RB患儿易双眼患病,且发病更早

Abstract:

ObjectiveTo analyze the characteristics of gene mutations and clinical phenotypes in children with retinoblastoma. MethodsWe performed molecular genetic screening in 23 children with sporadic retinoblastoma (bilateral in 4 and unilateral in 19 children) treated in 2018 to 2019 in the Second Affiliated Hospital of Chongqing Medical University by whole exon sequencing and methylation sequencing of the peripheral blood samples. The sequence data were analyzed in relation with the clinical features of the patients to explore the correlation between the genotypes and clinical phenotypes. ResultsFive pathological germline mutations of RB1 gene were identified in the 23 cases, including 3 cases with point mutations in RB1 gene (nonsense mutation c.1333C>T, missense mutation c.380G>A, and frameshift mutation c.1940delT), 1 case with heterozygous deletion of exon 5-17 in RB1 gene and 1 with heterozygous deletion of about 14 Mb fragment of RB1 gene and its adjacent sequence. The patients with genetic mutation had an average onset age of 5.4 months, significantly younger than  the others (average onset age of 20.2 months).  and a significant correlation was found between gene mutations and the age of disease onset (P<0.01, r=0.592). The detection rate of gene mutations was significantly higher in cases of bilateral tumors than in those with unilateral tumor (3/4 vs 2/19; Chisquare=8.074, P<0.01). ConclusionWe identified for the first time 2 new germline copy number variants of RB1 gene in children with retinoblastoma, which expand the spectrum of RB1 gene variations. Germline variation of RB1 gene is associated with a higher likelihood of bilateral eye involvement and an earlier onset of retinoblastoma in children.

参考文献/References:

[1]BISHOP J O, MADSON E C. Retinoblastoma. Review of the current status[J]. Surv Ophthalmol, 1975, 19(6): 342-366.

[2]LUO C, DENG Y P. Retinoblastoma: concerning its initiation and treatment[J]. Int J Ophthalmol, 2013, 6(3): 397-401. DOI: 10.3980/j.issn.22223959.2013.03.26.

[3]KNUDSON A G. Mutation and cancer: statistical study of retinoblastoma[J]. Proc Natl Acad Sci USA, 1971, 68(4): 820-823.

[4]GANGULY A, NICHOLS K E, GRANT G, et al. Molecular karyotype of sporadic unilateral retinoblastoma tumors[J]. Retina,2009,29(7): 1002-1012.DOI: 10.1097/iae.0b013e3181a0be05.

[5]宋文凭, 邵荣光, 李亮. 视网膜母细胞瘤的治疗、基因组学和表观基因组学研究进展[J]. 中国生化药物杂志, 2016, 36(6): 1-5. DOI: 10.3969/j.issn.10051678.2016.06.01.

SONG W P, SHAO R G, LI L. Therapeutics, genomics and epigenomics of retinoblastoma[J]. Chin J Biochem Pharm, 2016, 36(6): 1-5. DOI: 10.3969/j.issn.10051678.2016.06.01.

[6]LINNMURPHREE A. Intraocular retinoblastoma: the case for a new group classification[J]. Ophthalmol Clin N Am, 2005, 18(1): 41-53. DOI: 10.1016/j.ohc.2004.11.003.

[7]SOLIMAN S E, RACHER H, ZHANG C Y, et al. Genetics and molecular diagnostics in retinoblastoma: an update[J]. Asia Pac J Ophthalmol(Phila), 2017, 6(2): 197-207. DOI: 10.22608/APO.201711.

[8]张靖, 姜华, 申刚, 等. 经眼动脉灌注化疗治疗视网膜母细胞瘤临床疗效多因素分析[J]. 介入放射学杂志, 2015, 24(12): 1062-1066. DOI: 10.3969/j.issn.1008794X.2015.12.009.

ZHANG J, JIANG H, SHEN G, et al. Percutaneous transcatheter chemotherapy via ophthalmic artery for retinoblastoma: a multivariate analysis of clinical curative effect[J]. J Interv Radiol, 2015, 24(12): 1062-1066. DOI: 10.3969/j.issn.1008794X.2015.12.009.

[9]何明燕, 安宇, 李刚, 等. 儿童视网膜母细胞瘤患者RB1基因胚系突变的特征分析[J]. 中华医学遗传学杂志, 2013, 30(5): 509-512.DOI: 10.3760/cma.j.issn.10039406.2013.05.001.

HE M Y, AN Y, LI G, et al. Characteristics of RB1 gene mutations in Chinese patients with retinoblastoma[J]. Chin J Med Genet, 2013, 30(5): 509-512. DOI: 10.3760/cma.j.issn.10039406.2013.05.001.

[10]RUSHLOW D E, MOL B M, KENNETT J Y, et al. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies[J]. Lancet Oncol, 2013,14(4): 327-334.DOI: 10.1016/S14702045(13)700457.

[11]CHEN Z, MORAN K, RICHARDSYUTZ J, et al. Enhanced sensitivity for detection of lowlevel germline mosaic RB1 mutations in sporadic retinoblastoma cases using deep semiconductor sequencing[J]. Hum Mutat, 2014, 35(3): 384-391. DOI: 10.1002/humu.22488.

[12]GROTTA S, D’ELIA G, SCAVELLI R, et al. Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma[J]. BMC Cancer, 2015, 15(1): 1-9. DOI: 10.1186/s1288501518540.

[13]YAHALOM C, MACAROV M, LAZERDERBEKO G, et al. Preimplantation genetic diagnosis as a strategy to prevent having a child born with an heritable eye disease[J]. Ophthalmic Genet, 2018, 39(4): 450-456. DOI: 10.1080/13816810.2018.1474368.

[14]顼晓琳, 李彬, 王怡琛, 等. 视网膜母细胞瘤自发退行的临床组织病理学分析[J]. 中华眼科杂志, 2014, 50(10): 729-732. DOI: 10.3760/cma.j.issn.04124081.2014.10.004.

XU X L, LI B, WANG Y C, et al. Retinoblastoma spontaneous regression: clinical and histopathologic analysis[J]. Chin J Ophthalmol, 2014, 50(10): 729-732. DOI: 10.3760/cma.j.issn.04124081.2014.10.004.

[15]孙为荣. 眼科病理学[M]. 北京: 人民卫生出版社, 1997: 397-400.

SUN W R. Ophthalmology pathology[M]. Beijing: People’s Health Press, 1997: 397-400.

[16]GREGER V, PASSARGE E, HPPING W, et al. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma[J]. Hum Genet, 1989, 83(2): 155-158. DOI: 10.1007/BF00286709.

[17]PRICE E A, KOLKIEWICZ K, PATEL R, et al. Detection and reporting of RB1 promoter hypermethylation in diagnostic screening[J]. Ophthalmic Genet, 2018, 39(4): 526-531. DOI: 10.1080/13816810.2018.1479432.

[18]刘茹, 高玲, 卢光琇, 等. RAS相关区域家族1A和死亡相关蛋白激酶基因启动子在视网膜母细胞瘤中的甲基化状态[J]. 中华眼科杂志, 2009, 45(7): 631-635. DOI: 10.3760/cma.j.issn.04124081.2009.07.011.

LIU R, GAO L, LU G X, et al. Methylation status of RASSFIA and DAPK promoter in retinoblastoma[J]. Chin J Ophthalmol, 2009,45(7): 631-635. DOI: 10.3760/cma.j.issn.04124081.2009.07.011.

[19]INDOVINA P, ACQUAVIVA A, DE FALCO G, et al. Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma[J]. J Cell Physiol, 2009, 223(1): 143-150. DOI: 10.1002/jcp.22019.

[20]ZHANG J H, BENAVENTE C A, MCEVOY J, et al. A novel retinoblastoma therapy from genomic and epigenetic analyses[J]. Nature, 2012, 481(7381): 329-334. DOI: 10.1038/nature10733.

[21]LIVIDE G, EPISTOLATO M C, AMENDUNI M, et al. Epigenetic and copy number variation analysis in retinoblastoma by MSMLPA[J]. Pathol Oncol Res, 2012, 18(3): 703-712. DOI: 10.1007/s1225301294988.

[22]SONG Z D, DU Y Y, TAO Y. Blockade of sonic hedgehog signaling decreases viability and induces apoptosis in retinoblastoma cells: The key role of the PI3K/Akt pathway[J]. Oncol Lett, 2017, 14(4): 4099-4105. DOI: 10.3892/ol.2017.6701.

[23]VANHAESEBROECK B, STEPHENS L, HAWKINS P. PI3K signalling: the path to discovery and understanding[J]. Nat Rev Mol Cell Biol, 2012, 13(3): 195-203. DOI: 10.1038/nrm3290.

[24]XU W T, YANG Z, LU N H. A new role for the PI3K/Akt signaling pathway in the epithelialmesenchymal transition[J]. Cell Adhesion Migr, 2015, 9(4): 317-324. DOI: 10.1080/19336918.2015.1016686.

[25]YE B, JIANG L L, XU H T, et al. Expression and PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis[J]. Int J Immunopathol Pharmacol, 2012, 25(3): 627-636. DOI: 10.1177/039463201202500309.

[26]陈长征, 郁想想. 重视开展视网膜母细胞瘤的基因诊断工作[J]. 中华实验眼科杂志, 2013, 31(7): 617-620. DOI: 10.3760/cma.j.issn.20950160.2013.07.001.

CHEN C Z, YU X X. The importance of carrying out the gene diagnosis for retinoblastoma[J]. Chin J Exp Ophthalmol, 2013, 31(7): 617-620. DOI: 10.3760/cma.j.issn.20950160.2013.07.001.

相似文献/References:

[1]许敏,吴晓云,李勇刚,等.CITED2基因CpG岛甲基化与先天性心脏病的关系[J].第三军医大学学报,2013,35(03):245.
 Xu Min,Wu Xiaoyun,Li Yonggang,et al.Relationship of CpG islands methylation of CITED2 and congenital heart disease[J].J Third Mil Med Univ,2013,35(18):245.
[2]雷明星,杨恬,连小华,等.GasderminA3基因突变对小鼠毛囊β-catenin表达的影响[J].第三军医大学学报,2010,32(05):442.
 Lei Mingxing,Yang Tian,Lian Xiaohua,et al.Effect of GasderminA3 gene mutation on β-catenin expression in mouse hair follicle in vivo[J].J Third Mil Med Univ,2010,32(18):442.
[3]舒岚,蒋利萍,战玉助,等.4例高IgE综合征的临床分析和基因诊断[J].第三军医大学学报,2011,33(14):1506.
 Shu Lan,Jiang Liping,Zhan Yuzhu,et al.Clinical and genetic diagnoses of 4 cases with hyper-IgE syndrome[J].J Third Mil Med Univ,2011,33(18):1506.
[4]曾莉,郭遂群,云径平,等.广东地区宫颈癌HPV52型E6基因突变分析[J].第三军医大学学报,2007,29(12):1234.
 ZENG Li,GUO Sui-qun,YUN Jing-ping,et al.Mutation of E6 genes of human papillomavirus type 52 in cervical cancer patients in Guangdong province[J].J Third Mil Med Univ,2007,29(18):1234.
[5]曲雯雯,范含笑,谢露,等.新生儿呼吸窘迫综合征SP-B+1 580基因表达及遗传多态性分析[J].第三军医大学学报,2012,34(20):2070.
 Qu Wenwen,Fan Hanxiao,Xie Lu,et al.Expression and polymorphism of surfactant protein B gene +1 580 in neonatal respiratory distress syndrome[J].J Third Mil Med Univ,2012,34(18):2070.
[6]郭春宝,邓春,邓兵,等.新生儿G-6-PD缺陷症的基因突变分析[J].第三军医大学学报,2004,26(16):0.[doi:10.16016/j.1000-5404.2004.16.036 ]
[7]张晓莉,府伟灵,薛强,等.RHO基因突变在视网膜色素变性中的分子遗传学分析[J].第三军医大学学报,2002,24(01):0.[doi:10.16016/j.1000-5404.2002.01.024 ]
 ZHANG Xiao li,FU Wei ling,XUE Qiang,et al.[J].J Third Mil Med Univ,2002,24(18):0.[doi:10.16016/j.1000-5404.2002.01.024 ]
[8]宫亮.肺癌患者p53、K-ras基因突变与吸烟关系的Meta分析[J].第三军医大学学报,2002,24(02):0.[doi:10.16016/j.1000-5404.2002.02.061 ]
[9]尹晓娟,李为明,魏红光,等.100例重庆市汉族儿童哮喘α1-抗糜蛋白酶基因突变初探[J].第三军医大学学报,2000,22(01):0.[doi:10.16016/j.1000-5404.2000.01.017 ]
 YIN Xiao juan,LI Wei ming,WEI Hong guang,et al.[J].J Third Mil Med Univ,2000,22(18):0.[doi:10.16016/j.1000-5404.2000.01.017 ]
[10]周林,张国元,万大方,等.高血压病线粒体基因突变的研究[J].第三军医大学学报,1997,19(06):0.[doi:10.16016/j.1000-5404.1997.06.017 ]

更新日期/Last Update: 2020-09-22